HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Contributions of biological tumor parameters to the incorporation rate of L: -[methyl-(11)C] methionine into astrocytomas and oligodendrogliomas.

Abstract
We compared the tumor uptake of (11)C-methionine (MET) with positron emission tomography (PET) with the results of a pathological analysis to examine the proliferative potential and microvessel density measured with immunostaining for MIB-1 and factor VIII, respectively, from 33 patients with glioma. The MET uptake in oligodendrogliomas was significantly greater than that in grade 2 astrocytomas and comparable to those in grade 3 and 4 astrocytomas. The MIB-1 index of oligodendroglioma meanwhile was comparable to that of grade 2 astrocytoma. The microvessel area in oligodendroglioma was significantly greater than that in grade 2 astrocytomas and comparable to those in grade 3 and 4 astrocytomas. According to a multivariate statistical analysis, MET uptake ratio was closely correlated with the MIB-1 index among astrocytomas. An increase in the microvessel area in the oligodendrogliomas contributed to the higher MET uptake among the tumors with a low-proliferative index. This information is important for interpreting the results of MET-PET studies for clinical use.
AuthorsTakeko Nojiri, Tadashi Nariai, Masaru Aoyagi, Michio Senda, Kenji Ishii, Kiichi Ishiwata, Kikuo Ohno
JournalJournal of neuro-oncology (J Neurooncol) Vol. 93 Issue 2 Pg. 233-41 (Jun 2009) ISSN: 1573-7373 [Electronic] United States
PMID19099197 (Publication Type: Journal Article)
Chemical References
  • Carbon Radioisotopes
  • Factor VIII
  • Methionine
Topics
  • Adult
  • Astrocytoma (blood supply, diagnostic imaging, metabolism, pathology, surgery)
  • Capillaries (metabolism, pathology)
  • Carbon Radioisotopes
  • Cell Division
  • Factor VIII (metabolism)
  • Female
  • Humans
  • Male
  • Methionine (metabolism)
  • Microcirculation
  • Middle Aged
  • Neoplasm Staging
  • Oligodendroglioma (blood supply, diagnostic imaging, metabolism, pathology, surgery)
  • Positron-Emission Tomography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: